Found 21 matching trials
A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid Tumors PHASE1 This is a prospective, single-arm, open-label Phase 1 dose-finding and expa...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer. EARLY_PHASE1 This is an open-label, single-arm clinical study designed to evaluate the s...
Show More Location
Hainan Cancer Hospital
Learn More & Join Trial
Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T NA The efficacy of advanced pancreatic cancer and gastric cancer needs to be f...
Show More Learn More & Join Trial
An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects EARLY_PHASE1 An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Anti...
Show More Location
Shenzhen Luohu Hospital
Learn More & Join Trial
Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma NA A single arm, open-label pilot study is designed to determine the safety, t...
Show More Location
Changhai Hospital
Learn More & Join Trial
Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial NA The goal of this clinical trial is to assessing the safety and tolerability...
Show More Location
The Affiliated Hospital of Qingdao University
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer PHASE1 An open-label, single-arm, multicenter, Phase Ib clinical trial to evaluate...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors NA A single arm, open-label pilot study is designed to determine the safety, e...
Show More Location
First Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors PHASE1 An Open-Label, Single-Arm, Dose-Exploration Study to Evaluate the Safety, T...
Show More Location
Beijing Cancer Hospital, Beijing, China
Learn More & Join Trial
A Phase I Trial to Evaluate the Safety of IMC002 in Advanced Digestive System Tumors PHASE1 This is an open-label, multi-center, dose-escalation clinical study to eval...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial